AbCellera Biologics Inc (ABCL)
3.63
-0.27
(-6.92%)
USD |
NASDAQ |
Apr 25, 16:00
3.70
+0.07
(+1.93%)
After-Hours: 07:02
AbCellera Biologics Shareholders Equity (Quarterly): 1.152B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.152B |
| September 30, 2023 | 1.183B |
| June 30, 2023 | 1.195B |
| March 31, 2023 | 1.208B |
| December 31, 2022 | 1.233B |
| September 30, 2022 | 1.250B |
| June 30, 2022 | 1.213B |
| March 31, 2022 | 1.208B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.026B |
| September 30, 2021 | 953.40M |
| June 30, 2021 | 967.68M |
| March 31, 2021 | 957.12M |
| December 31, 2020 | 830.51M |
| September 30, 2020 | 89.24M |
| December 31, 2019 | 10.25M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.25M
Minimum
Dec 2019
1.250B
Maximum
Sep 2022
965.08M
Average
1.152B
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
| InMed Pharmaceuticals Inc | 12.77M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.488B |
| Total Liabilities (Quarterly) | 335.78M |
| Current Ratio | 7.327 |